When is it Cool to Drool? Oral Fluid Testing for Controlled Substance Monitoring - Insights
PACE / State of FLThis webinar will describe substance use disorders and the common laboratory tests and matrices used for controlled substance monitoring. The advantages and challenges of using oral fluid will be discussed along with how...
Sarcoma Targeted Gene Panel [Test in Focus] - Insights
Andre Oliveira, M.D., Ph.D., gives an overview of this testing available through Mayo Clinic Laboratories. He discusses when this testing should be ordered, how this testing compares to previous testing approaches, and what clinical action...
People Archives - Page 13 of 35 - Insights
Skip to Content MayoACCESS MayoLINK...
MML Regional Manager Kate Lynch Bix Retires after 29 Years of Dedicated Service - Insights
Kate Lynch Bix, Mayo Medical Laboratories (MML) Regional Manager, says goodbye after 29 years of dedicated service. When Kate joined MML in 1988, she joined the team of only eight sales staff responsible for covering the entire United...
Learn more about how Mayo Clinic Laboratories’ targeted, high-resolution screening panel for stimulant use identifies and confirms the presence of 10 stimulants and phencyclidine (PCP) with a single test.
Mayo Clinic Laboratories’ pharmacogenomic testing offers superior analytical quality, enabling targeted detection of more clinically actionable alleles than other testing.
Answers From the Lab - Insights
A Mayo Clinic podcast sharing knowledge and advances in testing, laboratory science, and the people who make it all happen behind the scenes. Note: Podcasts will not play back on Internet Explorer. Please use an alternative web browser, or...
Mayo Clinic Laboratory and Pathology Research Roundup: March 20 - Insights
This week’s Research Roundup highlights how AKT-phosphorylated FOXO1 suppresses ERK activation and chemoresistance by disrupting IQGAP1-MAPK interaction.
Mayo Clinic Laboratory and Pathology Research Roundup: May 1 - Insights
This week’s Research Roundup highlights the association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery.
Precision pain management - Insights
Our liquid chromatography-tandem mass spectrometry, high-resolution accurate mass (LC-MS/MS HRAM) screens, and confirmatory testing for controlled substances are available based on the needs of your patients.